NCT03181048 Clinical Trial of Concomitant Hip Arthroscopy During PAO
| NCT ID | NCT03181048 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Hip Dysplasia |
| Study Type | INTERVENTIONAL |
| Enrollment | 106 participants |
| Start Date | 2017-08-23 |
| Primary Completion | 2028-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 106 participants in total. It began in 2017-08-23 with a primary completion date of 2028-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study will assess the outcomes of patients treated with concomitant hip arthroscopy at the time of periacetabular osteotomy (PAO) for patients with hip dysplasia compared with patients treated with PAO alone.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of hip dysplasia (DDH) electing periacetabular osteotomy (PAO) for treatment * Skeletally mature * Age 15 - 55 * Tonnis Grade 0 or 1 osteoarthritis (minimal or no arthritis) * Ability to receive a standard of care preoperative (magnetic resonance imaging) MRI arthrogram of the hip Exclusion Criteria: * Pregnant women * Previous surgery about the hip * Patients receiving PAO for acetabular retroversion in the absence of DDH * Previous hip arthroscopy to address intra-articular pathology
Contact & Investigator
Rafael Sierra, MD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT03181048 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 55 Years, studying Hip Dysplasia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03181048 currently recruiting?
Yes, NCT03181048 is actively recruiting participants. Contact the research team at wyles.cody@mayo.edu for enrollment information.
Where is the NCT03181048 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT03181048 clinical trial?
NCT03181048 is sponsored by Mayo Clinic. The principal investigator is Rafael Sierra, MD at Mayo Clinic. The trial plans to enroll 106 participants.